Organization type
- Academic research institution
- Contract research organization (CRO)
Early phases
- Biomarker identification
-
Omics
- Target identification – new biological hypothesis
- Target validation – Hypothesis verification
Screening
-
Assay development
- In vitro screening models
- In vivo screening models
Optimization phases
- In vitro biochemical models(including assay/model development and testing)
- In vivo animal models (including assay/model development and testing)
-
Mechanism of action (MoA) assessment
- Omics profiling
- Selectivity panels
-
Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
- ADME / DMPK
Terapeutic areas
- Cancer
- Cardiovascular
Additional activities
- Consulting services
- Government initiatives supporting drug and research collaborations